Targeted Gene Editing Is The Focus At Medics Therapeutics

bejo

6909

Share

Targeted Gene Editing Is The Focus At Medics Therapeutics

NLRX1 was prioritized based on its high statistical rank within our targeted functional pool (mitochondria-localized proteins and mitophagy receptors) and, most importantly, its subsequent robust.

In Vivo Gene Editing - Precision BioSciences

Figure 1 from Topical gene editing therapeutics using lipid ...